Zobrazeno 1 - 2
of 2
pro vyhledávání: '"G G, Roliano"'
Autor:
Ana Maria Oliveira Battastini, Elizandra Braganhol, Isabele Cristiana Iser, Juliete Nathali Scholl, Roselena Silvestri Schuh, Luana Roberta Michels, Jean Sévigny, Márcia Rosângela Wink, Helder Ferreira Teixeira, G. G. Roliano, Liziane Raquel Beckenkamp, Gabriela Spies Lenz, Fabrício Figueiró, Marco Antonio Stefani, Juliana Hofstatter Azambuja
Publikováno v:
Cancer Immunology, Immunotherapy. 69:1801-1812
Immunotherapy as an approach for cancer treatment is clinically promising. CD73, which is the enzyme that produces extracellular adenosine, favors cancer progression and protects the tumor from immune surveillance. While CD73 has recently been demons
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::8519276a44d55281374501b1f93ed3c9
https://doi.org/10.1007/s00262-020-02569-w
https://doi.org/10.1007/s00262-020-02569-w
Autor:
J H, Azambuja, R S, Schuh, L R, Michels, I C, Iser, L R, Beckenkamp, G G, Roliano, G S, Lenz, J N, Scholl, J, Sévigny, M R, Wink, M A, Stefani, A M O, Battastini, F, Figueiró, H F, Teixeira, E, Braganhol
Publikováno v:
Cancer immunology, immunotherapy : CII. 69(9)
Immunotherapy as an approach for cancer treatment is clinically promising. CD73, which is the enzyme that produces extracellular adenosine, favors cancer progression and protects the tumor from immune surveillance. While CD73 has recently been demons
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::4715cd5ea44fac0b5202ae79e938a9df
https://pubmed.ncbi.nlm.nih.gov/32350590
https://pubmed.ncbi.nlm.nih.gov/32350590